Monitoring of cyclooxygenase-2 levels can predict EGFR mutations and the efficacy of EGFR-TKI in patients with lung adenocarcinoma

Background: Epidermal growth factor receptor (EGFR) mutation detection has become a routine molecular test with significant implications for prognosis and therapeutic options of EGFR tyrosine kinase inhibitors (EGFR-TKIs). However, acquiring sufficient amounts of tissue for analyzing EGFR mutations...

Full description

Saved in:
Bibliographic Details
Published in:Int J Clin Exp Pathol
Main Authors: Li, Huanhuan, Wang, Yuli, Su, Fan, Li, Jing, Gong, Ping
Format: Artigo
Language:Inglês
Published: e-Century Publishing Corporation 2015
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4503138/
https://ncbi.nlm.nih.gov/pubmed/26191267
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items